Published in Clin Immunol Immunopathol on September 01, 1974
Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut (1976) 2.15
Association of HLA-A9 and HLA-B5 with Buerger's disease. Br Med J (1976) 1.28
Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8. Br Med J (1977) 1.16
Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis. J Neurol Neurosurg Psychiatry (1975) 0.80
HLA-B8, autoimmune polyendocrinopathy and systemic lupus erythematosus. Can Med Assoc J (1979) 0.75
Functional consequences of perceived interleukin deficiencies? Analysis employing NZB x C58 recombinant inbred mice. Clin Exp Immunol (1985) 0.75
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood (1995) 16.81
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell (1991) 8.98
The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature (1990) 5.24
Acute promyelocytic leukemia. N Engl J Med (1993) 4.63
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood (1990) 4.36
Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci U S A (1990) 3.09
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol (1998) 2.74
Antibody-induced redistribution of HL-A antigens at the cell surface. Eur J Immunol (1972) 2.58
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 2.54
The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene (1995) 2.23
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A (1997) 2.14
Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 2.05
A new method to test genetic models in HLA associated diseases: the MASC method. Ann Hum Genet (1988) 2.03
Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness. Diabetologia (1994) 2.03
Is there a limit to the normality of blood products? Hematol J (2000) 2.00
[The Center for the Study of Human Polymorphism]. Presse Med (1986) 1.94
Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med (1999) 1.91
Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature (1990) 1.87
PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood (1993) 1.82
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia (2006) 1.77
Genetics of HLA disease association. Annu Rev Genet (1981) 1.74
The major histocompatibility complex in man. Science (1981) 1.72
A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1985) 1.69
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A (1998) 1.63
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci U S A (1994) 1.57
Neutrophilic dermatoses during granulocytopenia. Arch Dermatol (1995) 1.56
Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol (2000) 1.56
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR. Leukemia (2000) 1.55
Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A (2001) 1.53
Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci U S A (1984) 1.52
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest (1990) 1.51
HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol (2001) 1.50
An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med (1980) 1.50
Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function. Blood (1978) 1.47
Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med (1988) 1.47
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol (1999) 1.46
Analysis of 221 renal transplants: influence of cross-reactions between donor and recipient HL-A antigens. Transplant Proc (1971) 1.45
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A (1997) 1.44
SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proc Natl Acad Sci U S A (1999) 1.44
Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat Med (1998) 1.44
Application of the lod score method to detection of linkage between HLA and juvenile insulin-dependent diabetes. Clin Genet (1980) 1.41
Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guideline. Hematol J (2000) 1.41
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol (1999) 1.41
Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40
Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A (2001) 1.38
HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. Hum Immunol (1982) 1.37
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. Br J Haematol (2000) 1.37
A molecular defect in thrombasthenic platelets. J Clin Invest (1975) 1.36
A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. Tissue Antigens (1978) 1.35
HLA genotype studies in juvenile insulin-dependent diabetes. Diabetologia (1980) 1.34
Polymorphic restriction endonuclease fragment segregates and correlates with the gene for HLA-B8. Proc Natl Acad Sci U S A (1983) 1.33
Clusters of HLA class II beta restriction fragments describe allelic series. Proc Natl Acad Sci U S A (1984) 1.32
A study of HL-A antigens in human organs. Transplantation (1970) 1.32
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia (2000) 1.31
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol (1990) 1.30
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood (1990) 1.30
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations. J Exp Med (1987) 1.28
The HL-A system sub-loci and their importance in transplantation. Transplant Proc (1969) 1.27
Ranks of donor-recipient histocompatibility for human transplantation. Science (1970) 1.24
An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A (1994) 1.23
Use of the Auto-Analyzer to perform serological tests for syphilis. Study of 1,009 sera using a complement fixation test with the cardiolipidic antigen. Int Arch Allergy Appl Immunol (1967) 1.23
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am (2000) 1.22
Serologic factors in human transplantation. Ann Surg (1967) 1.22
Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron. J Exp Med (1990) 1.22
HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. Tissue Antigens (1982) 1.19
Theoretical analysis of a physical mapping strategy using random single-copy landmarks. Proc Natl Acad Sci U S A (1991) 1.19
Improved control of partial DNA restriction enzyme digest in agarose using limiting concentrations of Mg++. Nucleic Acids Res (1989) 1.18
Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol (2000) 1.18
Immunoferritin study of the distribution of HL-A antigens on human blood cells. J Immunol (1971) 1.17
Human transplantation antigens: the HL-A (Hu-1) system and its homology with the mouse H-2 system. Transplantation (1968) 1.17
HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol (1999) 1.16
Critical evaluation of histocompatibility in 179 renal transplants. Lancet (1971) 1.16
Regional mapping of the HLA on the short arm of chromosome 6. Clin Genet (1979) 1.15
Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol (1981) 1.15
Juvenile insulin-dependent diabetes: a possible susceptibility gene in interaction with HLA. Ann Hum Genet (1981) 1.15
The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication? Immunogenetics (1989) 1.14
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol (2004) 1.13
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia (2003) 1.13
Complementation and maternal effect in insulin-dependent diabetes. Am J Hum Genet (1991) 1.12
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol (2001) 1.12
HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis (1982) 1.11
Probable heploid expression of HL-A antigens on human spermatozoon. Nature (1970) 1.10
First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet (1986) 1.10